Evaluating how telehealth can improve a diabetes prevention program for employees
Putting Telehealth to the Test: An Evaluation of the Use of Telehealth to Increase the Population-Level Impact of an Employer-Based Diabetes Prevention Program
This study is looking at how using online health sessions can help more employees join a diabetes prevention program, making it easier for them to lose weight and lower their risk of diabetes, even if they have busy schedules or can't get to in-person meetings.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10669641 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of using telehealth to enhance the reach and impact of an employer-based diabetes prevention program. By leveraging technology, the program aims to overcome barriers such as inconvenient locations and time constraints that prevent employees from participating. Participants will engage in virtual sessions designed to help them achieve weight loss goals and reduce their risk of diabetes. The study will assess how well telehealth can facilitate participation and improve health outcomes for employees.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are employees of participating organizations and are at risk for developing diabetes.
Not a fit: Patients who are not employees of the participating organizations or those who do not have access to telehealth services may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to increased participation in diabetes prevention programs, ultimately reducing the incidence of diabetes among employees.
How similar studies have performed: Previous research has shown that telehealth can effectively increase participation in health programs, suggesting a promising approach for this initiative.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Chakkalakal, Rosette J — Emory University
- Study coordinator: Chakkalakal, Rosette J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.